{"uid":"cap_T7Kj7STPRlMmSTnOKUCPe","slug":"clinical-memoryapi-org-f1e6f499","name":"Clinical Trials by Sponsor","description":"All clinical trials by a sponsor company. Track a biotech/pharma company complete trial portfolio.","url":"https://clinical.memoryapi.org/x402/clinical/sponsor","method":"GET","headers":{},"bodySchema":{"properties":{"input":{"required":["method"],"properties":{"method":{"enum":["GET"],"type":"string"}}}}},"responseSchema":null,"example":{"request":{"sponsor":"Pfizer"},"response":{"count":20,"source":"ClinicalTrials.gov","trials":[{"url":"https://clinicaltrials.gov/study/NCT00676650","phase":["PHASE3"],"title":"Sunitinib Plus Prednisone In Patients With Metastatic Castration-Resistant Prostate Cancer After Failure Of Docetaxel Chemotherapy","nct_id":"NCT00676650","status":"TERMINATED","conditions":["Prostatic Neoplasms"],"enrollment":873,"start_date":"2008-07","completion_date":"2011-12"},{"url":"https://clinicaltrials.gov/study/NCT00159913","phase":["PHASE3"],"title":"A Randomized, Double-Blind, Placebo-Controlled Study of Sildenafil in Children With Pulmonary Arterial Hypertension.","nct_id":"NCT00159913","status":"COMPLETED","conditions":["Pulmonary Arterial Hypertension, Children"],"enrollment":235,"start_date":"2003-08","completion_date":"2008-06"},{"url":"https://clinicaltrials.gov/study/NCT01348308","phase":["PHASE3"],"title":"Immuno-stimulation With Maraviroc Combined to Antiretroviral Therapy in Advanced Late Diagnosed HIV-1 Infected Patients","nct_id":"NCT01348308","status":"COMPLETED","conditions":["HIV-1 Infection","AIDS"],"enrollment":407,"start_date":"2011-09","completion_date":"2016-03"},{"url":"https://clinicaltrials.gov/study/NCT01768117","phase":["PHASE2"],"title":"Study To Describe The Safety, Tolerability, And Immunogenicity Of Bivalent Rlp2086 Vaccine In Laboratory Workers ≥18 To ≤65 Years Of Age","nct_id":"NCT01768117","status":"COMPLETED","conditions":["Meningitis, Meningococcal, Serogroup B"],"enrollment":13,"start_date":"2013-02","completion_date":"2014-02"},{"url":"https://clinicaltrials.gov/study/NCT00137410","phase":["PHASE3"],"title":"Celebrex Short Versus Long Therapy In Osteoarthritis Of The Knee","nct_id":"NCT00137410","status":"COMPLETED","conditions":["Osteoarthritis,Knee"],"enrollment":200,"start_date":"2002-11","completion_date":"2006-03"},{"url":"https://clinicaltrials.gov/study/NCT01512160","phase":["PHASE2"],"title":"Efficacy Of Pf-04531083 In Treating Post-Surgical Dental Pain","nct_id":"NCT01512160","status":"TERMINATED","conditions":["Post-surgical Dental Pain"],"enrollment":90,"start_date":"2011-10","completion_date":"2012-05"},{"url":"https://clinicaltrials.gov/study/NCT00684424","title":"Non-Interventional Study With LYRICA (Pregabalin) In Patients With Epilepsy As Adjunctive Therapy Of Partial Seizures To Reduce Seizure Frequency","nct_id":"NCT00684424","status":"COMPLETED","conditions":["Epilepsy"],"enrollment":199,"start_date":"2008-07","completion_date":"2009-03"},{"url":"https://clinicaltrials.gov/study/NCT00545129","phase":["PHASE2"],"title":"A Study Of Tanezumab as Add-On Therapy to Opioid Medication In Patients With Pain Due To Cancer That Has Spread To Bone","nct_id":"NCT00545129","status":"COMPLETED","conditions":["Neoplasm Metastasis","Palliative Care"],"enrollment":59,"start_date":"2009-04-29","completion_date":"2012-02-07"},{"url":"https://clinicaltrials.gov/study/NCT02188667","phase":["NA"],"title":"Integrating Patient Reported Outcomes (I-PRO) Study for Multidisciplinary Pain Care","nct_id":"NCT02188667","status":"COMPLETED","conditions":["Chronic Noncancer Pain"],"enrollment":21,"start_date":"2014-07","completion_date":"2016-03"},{"url":"https://clinicaltrials.gov/study/NCT00800267","phase":["PHASE3"],"title":"A Study of Glaucoma or Ocular Hypertension in Patients Within the United States","nct_id":"NCT00800267","status":"COMPLETED","conditions":["Ocular Hypertension","Glaucoma"],"enrollment":418,"start_date":"1997-07","completion_date":"1999-06"},{"url":"https://clinicaltrials.gov/study/NCT07519655","phase":["PHASE1"],"title":"Phase 1 Study of PF-08046033 in Advanced Solid Tumors","nct_id":"NCT07519655","status":"RECRUITING","conditions":["Non-Small-Cell Lung","Esophageal Cancer","Cutaneous Melanoma"],"enrollment":250,"start_date":"2026-04-08","completion_date":"2029-07-14"},{"url":"https://clinicaltrials.gov/study/NCT06163326","phase":["PHASE3"],"title":"A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Participants With Nonsegmental Vitiligo","nct_id":"NCT06163326","status":"ACTIVE_NOT_RECRUITING","conditions":["Vitiligo"],"enrollment":394,"start_date":"2024-01-19","completion_date":"2027-03-31"},{"url":"https://clinicaltrials.gov/study/NCT00082576","phase":["PHASE2","PHASE3"],"title":"Azithromycin Plus Chloroquine Versus Mefloquine for the Treatment of Uncomplicated Malaria in Africa","nct_id":"NCT00082576","status":"COMPLETED","conditions":["Malaria, Falciparum"],"enrollment":238,"start_date":"2004-06","completion_date":"2006-05"},{"url":"https://clinicaltrials.gov/study/NCT00725686","phase":["PHASE1"],"title":"Study of PF-04523655 (REDD14NP) In Subjects With Choroidal Neovascularization (CNV) Secondary to Age-Related Macular Degeneration (Wet AMD)","nct_id":"NCT00725686","status":"COMPLETED","conditions":["Age-Related Macular Degeneration"],"enrollment":54,"start_date":"2007-02","completion_date":"2010-11"},{"url":"https://clinicaltrials.gov/study/NCT00676429","phase":["PHASE2"],"title":"Ziprasidone for Severe Conduct and Other Disruptive Behavior Disorders","nct_id":"NCT00676429","status":"COMPLETED","conditions":["Conduct Disorder","Oppositional Defiant Disorder"],"enrollment":51,"start_date":"2006-07","completion_date":"2008-06"},{"url":"https://clinicaltrials.gov/study/NCT00827931","phase":["PHASE4"],"title":"Study Of Tranexamic Acid For The Reduction Of Blood Loss In Patients Undergoing Major Abdominal Surgery","nct_id":"NCT00827931","status":"COMPLETED","conditions":["Biliary Tract Surgical Procedures","Pancreaticoduodenectomy","Esophagectomy"],"enrollment":94,"start_date":"2009-09","completion_date":"2011-05"},{"url":"https://clinicaltrials.gov/study/NCT05905341","phase":["PHASE1"],"title":"Study of PF-07224826, as a Single Agent or in Combination With Endocrine Therapy in Participants With Breast Cancer and Other Advanced Solid Tumors.","nct_id":"NCT05905341","status":"WITHDRAWN","conditions":["Breast Cancer","Ovarian Cancer","Liposarcoma"],"enrollment":0,"start_date":"2024-01-15","completion_date":"2028-04-13"},{"url":"https://clinicaltrials.gov/study/NCT00159822","phase":["PHASE2","PHASE3"],"title":"Voriconazole For Chronic Bronchopulmonary Aspergillosis","nct_id":"NCT00159822","status":"COMPLETED","conditions":["Aspergillosis"],"enrollment":48,"start_date":"2005-07","completion_date":"2008-12"},{"url":"https://clinicaltrials.gov/study/NCT04071405","title":"Korea Post-marketing Surveillance for Xeljanz (Registered) in Ulcerative Colitis Patients","nct_id":"NCT04071405","status":"COMPLETED","conditions":["Ulcerative Colitis"],"enrollment":110,"start_date":"2020-05-12","completion_date":"2022-09-26"},{"url":"https://clinicaltrials.gov/study/NCT00218205","phase":["PHASE2"],"title":"A Study of Epirubicin With Estramustine Phosphate and Celecoxib for the Treatment of Prostate Cancer","nct_id":"NCT00218205","status":"UNKNOWN","conditions":["Prostate Cancer"],"enrollment":28,"start_date":"2002-07","completion_date":"2006-06"}],"sponsor":"Pfizer","success":true,"status_filter":"all"}},"exampleRequest":{"sponsor":"Pfizer"},"tags":["x402"],"displayCostAmount":"0.005","displayCostAsset":"USDC","priceDynamic":false,"priceHint":null,"priceStatus":"priced","priceSource":"settled","requiresHandshake":false,"reviewCount":0,"rating":{"score":"0.00","successRate":"0.00","reviews":0,"stars":null,"state":"unrated"},"availabilityStatus":"unknown","priceObserved":null,"sessionDeposit":null,"pricing":{"kind":"static","summary":"$0.005/call","primary":{"kind":"static","protocol":"x402","network":"base","amountUsd":"0.005","per":"call","confidence":"exact"},"accepted":[{"kind":"static","protocol":"x402","network":"base","amountUsd":"0.005","per":"call","confidence":"exact"}]},"paymentMethods":[{"uid":"pm_UhBuhKQ5uOEEgxLgfFmCJ","protocol":"x402","methodType":"crypto","chain":"base","mode":"charge","costAmount":"0.005","costPer":"request","priority":0,"asset":"0x833589fCD6eDb6E08f4c7C32D4f71b54bdA02913","unit":"request","depositMicros":null,"planRef":null}],"brandName":null,"brandSlug":null,"brandBaseUrl":null,"brandDocsUrl":null,"whatItDoes":"Returns all clinical trials in a sponsor company's portfolio from ClinicalTrials.gov","exampleAgentPrompt":"Pull up the complete clinical trial portfolio for Pfizer from ClinicalTrials.gov — I want to see every trial they're sponsoring, across all phases and conditions.","exampleUseCases":null,"resultDescription":"A list of all clinical trials associated with the specified sponsor company, including trial identifiers (NCT IDs), statuses, phases, conditions studied, and related metadata sourced from ClinicalTrials.gov.","failureModes":["Sponsor name not found or misspelled — returns empty results or error","Ambiguous sponsor name matching multiple organizations — may return incomplete results","ClinicalTrials.gov upstream unavailability — service timeout or error response","Payment failure via x402 protocol — request not processed"],"whenToPreferThis":"Use this endpoint when you need a complete view of all trials run by a single sponsor company, such as for competitive intelligence, pipeline analysis, or tracking a specific pharma/biotech organization's research activity. Prefer this over the condition-based or search endpoints when the primary axis of interest is the sponsor rather than a disease area.","instructions":null,"reviewSummary":null,"reviewSummaryHighlights":null,"reviewSummaryConcerns":null,"reviewSummaryGeneratedAt":null,"activationCount":0,"lastUsedAt":null,"lastSuccessfullyRanAt":null,"lastHealthCheckAt":"2026-09-15T00:42:02.555Z","isFirstParty":false}